Filing Details

Accession Number:
0001127602-25-012727
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-04-29 16:04:40
Reporting Period:
2025-04-25
Filing Date:
2025-04-29
Accepted Time:
2025-04-29 16:04:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
310158 Merck & Co. Inc. MRK Pharmaceutical Preparations (2834) 221918501
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2003375 Iii E. Dalton Smart 126 East Lincoln Avenue
Rahway NJ 07065
Svp Fin. - Global Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-04-25 5,000 $58.08 12,040 No 4 M Direct
Common Stock Disposition 2025-04-25 4,262 $82.76 7,778 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2025-04-25 5,000 $0.00 5,000 $58.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-05-01 2025-04-30 No 4 M Direct
Footnotes
  1. Holdings include shares acquired in dividend reinvestment transactions.
  2. The option became exercisable in equal installments on 5/1/2016, 5/1/2017 and 5/1/2018.